Resultados da busca - Mitch A. Phelps

CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation por Nathan D. Seligson, Nathan D. Seligson, Nathan D. Seligson, Xunjie Zhang, Mark C. Zemanek, Jasmine A. Johnson, Zachary VanGundy, Danxin Wang, Mitch A. Phelps, Mitch A. Phelps, Julianna Roddy, Julianna Roddy, Craig C. Hofmeister, Junan Li, Junan Li, Ming J. Poi, Ming J. Poi, Ming J. Poi

Connect to this object online.

Approaches to handling missing or "problematic" pharmacology data: Pharmacokinetics por Donald J. Irby, Mustafa E. Ibrahim, Anees M. Dauki, Mohamed A. Badawi, Sílvia M. Illamola, Mingqing Chen, Yuhuan Wang, Xiaoxi Liu, Mitch A. Phelps, Diane R. Mould

Connect to this object online.

Pharmacological Prevention of Neonatal Opioid Withdrawal in a Pregnant Guinea Pig Model por Alireza Safa, Allison R. Lau, Sydney Aten, Karl Schilling, Karen L. Bales, Victoria A. Miller, Julie Fitzgerald, Min Chen, Kasey Hill, Kyle Dzwigalski, Karl Obrietan, Mitch A. Phelps, Wolfgang Sadee, Wolfgang Sadee, John Oberdick

Connect to this object online.

Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans por Alyssa Marie M. Castillo, Trang T. Vu, Sophia G. Liva, Min Chen, Zhiliang Xie, Justin Thomas, Bryan Remaily, Yizhen Guo, Uma L. Subrayan, Travis Costa, Timothy H. Helms, Donald J. Irby, Kyeongmin Kim, Dwight H. Owen, Samuel K. Kulp, Thomas A. Mace, Mitch A. Phelps, Christopher C. Coss

Connect to this object online.

Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia por Trang T. Vu, Kyeongmin Kim, Millennium Manna, Justin Thomas, Bryan C. Remaily, Emma J. Montgomery, Travis Costa, Lauren Granchie, Zhiliang Xie, Yizhen Guo, Min Chen, Alyssa Marie M. Castillo, Samuel K. Kulp, Xiaokui Mo, Sridhar Nimmagadda, Paul Gregorevic, Dwight H. Owen, Latha P. Ganesan, Thomas A. Mace, Christopher C. Coss, Mitch A. Phelps

Connect to this object online.